Stay updated on Coxib for Duodenal Polyp Growth Clinical Trial
Sign up to get notified when there's something new on the Coxib for Duodenal Polyp Growth Clinical Trial page.

Latest updates to the Coxib for Duodenal Polyp Growth Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe ClinicalTrials.gov record for the FAP duodenal-polyp study is displayed with its study design, rofecoxib and placebo arms, participant criteria, location, and record history.SummaryDifference30%

- Check17 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.2 to v3.8.0. The study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA banner announces NIH’s website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.” It appears above a ClinicalTrials.gov page showing a 403 error.SummaryDifference1%

- Check31 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check38 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1; the page continues to display a 403 error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content with an access-denied screen. This indicates the page is no longer serving the expected study details and navigation, providing limited information to users.SummaryDifference14%

Stay in the know with updates to Coxib for Duodenal Polyp Growth Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Coxib for Duodenal Polyp Growth Clinical Trial page.